Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets

Karly C. Sourris(Baker Heart and Diabetes Institute), Josephine M. Forbes(Translational Research Institute)
Current Drug Targets
January 1, 2009
Cited by 98


Related Papers